Iantrek, Inc.
Clinical trials sponsored by Iantrek, Inc., explained in plain language.
-
New glaucoma surgery under the microscope: 300 patients tracked for 2 years
Disease control OngoingThis study follows 300 adults with open-angle glaucoma who had a surgery called CycloPen™ to lower eye pressure. Researchers will check if the surgery safely reduces eye pressure by at least 20% and if patients need fewer eye drops over 24 months. The goal is to see how well this…
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New eye surgery could help glaucoma patients ditch drops
Disease control ENROLLING_BY_INVITATIONThis study is watching 300 people with open-angle glaucoma who get a new type of eye surgery called bio-reinforced canaloplasty. The surgery aims to improve fluid drainage inside the eye to lower pressure. Participants will have regular eye check-ups for two years to see how well…
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New surgical tool aims to lower eye pressure in glaucoma patients
Disease control OngoingThis study follows 100 adults with primary open-angle glaucoma who had a goniotomy procedure using the C-Rex surgical instrument. The goal is to see how well the surgery lowers intraocular pressure and reduces the need for glaucoma medications over 12 months. Researchers will als…
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Glaucoma surgery checked 5 years later: does it hold up?
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 250 people with open-angle glaucoma who had a new type of surgery called CycloPen, which aims to improve fluid drainage from the eye. Researchers will measure eye pressure at 3, 4, and 5 years after surgery to see if the benefits last. The goal is to understand…
Sponsor: Iantrek, Inc. • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC